Eli Lilly and Company
COMPANY DATA
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog…
PRICE HISTORY
1D
-1.8 %
1W
-5.3 %
1M
+1.2 %
6M
+17.8 %
YTD
+12.8 %
1Y
+64.7 %
2Y
+27.5 %
5Y
+366.6 %
10Y
+1,449.1 %
EARNINGS
Next earnings date
29/10/2026 (in 64 days)
Volatility around earnings
~91% stronger price swings than usual
PATTERN CHART
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 19/08/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
SCORES
Valuation roughly in line with its historical average.
Clear uptrend.
Average balance sheet quality.
Unremarkable dividend history.
Weak growth or expensive relative to it.
Insiders are selling more shares than they buy.
Roughly meets expectations.
Not enough data yet for an assessment.
Negative social media sentiment.
Elevated short volume ratio.
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 26/08/2026.
ASK THE AGENTS ABOUT LLY
ANALYST ASSESSMENT
PRICE TARGET LOW
US$1,135.00
CONSENSUS
US$1,341.63
MEDIAN
US$1,360.00
PRICE TARGET HIGH
US$1,500.00
0
STRONG BUY
33
BUY
9
HOLD
3
SELL
0
STRONG SELL
45
TOTAL · Buy
| DATE | ANALYST FIRM | RATING | ACTION |
|---|---|---|---|
| 07/08/2026 | Truist Securities | Buy | maintain |
| 06/08/2026 | Cantor Fitzgerald | Overweight | maintain |
| 06/08/2026 | Wells Fargo | Overweight | maintain |
| 15/07/2026 | Citigroup | Buy | maintain |
| 14/07/2026 | Bernstein | Outperform | maintain |
| 13/07/2026 | Guggenheim | Buy | maintain |
| 13/07/2026 | UBS | Buy | maintain |
| 10/07/2026 | B of A Securities | Buy | maintain |
METRICS
P/E
40.64
P/B
31.95
EV/EBITDA
33.75
RETURN ON EQUITY
20.9 %
NET MARGIN
30.9 %
DEBT/EQUITY
1.62
DIVIDEND YIELD
0.6 %
AS OF
30/06/2026
FREE FLOAT & LIQUIDITY
FREE FLOAT
90.1 %
FLOAT SHARES
848,690,397
AVG. DAILY VOLUME (30D)
2,587,019
INSIDER TRANSACTIONS (SEC)
| DATE | INSIDER | ROLE | TRANSACTION | SHARES | PRICE | PLAN TYPE |
|---|---|---|---|---|---|---|
| 18/08/2026 | Fyrwald J Erik | Director | Grant | 8 | 1,183.16 | Spontaneous |
| 18/08/2026 | Jonsson Patrik | Officer | Sale | 6,500 | 1,175.1 | Pre-planned |
| 18/08/2026 | Alvarez Ralph | Director | Grant | 10 | 1,183.16 | Spontaneous |
| 18/08/2026 | Sulzberger Gabrielle | Director | Grant | 4 | 1,183.16 | Spontaneous |
| 18/08/2026 | LUCIANO JUAN R | Director | Grant | 13 | 1,183.16 | Spontaneous |
ATTENTION
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.8%
Forums (Reddit)
INSTITUTIONAL HOLDERS
| FUND / INSTITUTION | SHARES | CHANGE | AS OF |
|---|---|---|---|
| LILLY ENDOWMENT INC | 90,376,978 | -1,520,000 | 30/06/2026 |
| BlackRock, Inc. | 67,540,400 | +1,159,558 | 30/06/2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 53,528,868 | +167,094 | 30/06/2026 |
| PNC FINANCIAL SERVICES GROUP, INC. | 51,322,720 | -6,188 | 30/06/2026 |
| STATE STREET CORP | 36,215,754 | +605,752 | 30/06/2026 |
DIVIDENDS
| EX-DATE | PAY DATE | AMOUNT | YIELD |
|---|---|---|---|
| 14/08/2026 | 10/09/2026 | US$1.73 | 0.6 % |
| 15/05/2026 | 10/06/2026 | US$1.73 | 0.6 % |
| 13/02/2026 | 10/03/2026 | US$1.73 | 0.6 % |
| 14/11/2025 | 10/12/2025 | US$1.50 | 0.6 % |
| 15/08/2025 | 10/09/2025 | US$1.50 | 0.8 % |
STOCK SPLITS
| DATE | RATIO |
|---|---|
| 16/10/1997 | 2:1 |
| 21/12/1995 | 2:1 |
| 01/05/1989 | 2:1 |
| 30/01/1986 | 2:1 |
Not investment advice. Past performance is not an indicator of future results.